These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2841004)

  • 1. Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behaviour, body weight and core temperature in the rat.
    Millan MJ; Morris BJ
    Brain Res; 1988 May; 450(1-2):247-58. PubMed ID: 2841004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
    Millan MJ; Colpaert FC
    Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the mediobasal arcuate hypothalamus in relation to opioid systems in the control of ingestive behaviour in the rat.
    Millan MJ; Millan MH; Reid LD; Herz A
    Brain Res; 1986 Aug; 381(1):29-42. PubMed ID: 2875765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of sustained opioid receptor blockade in a model of long-term, localized inflammatory pain in rats.
    Millan MJ; Colpaert FC
    Neurosci Lett; 1990 May; 113(1):50-5. PubMed ID: 2164176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiatergic modulation of preparatory and consummatory components of feeding and drinking.
    Nencini P; Graziani M
    Pharmacol Biochem Behav; 1990 Nov; 37(3):531-7. PubMed ID: 1965043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-ratio comparison of mu and kappa agonists in formalin and thermal pain.
    Abbott FV; Franklin KB; Libman RB
    Life Sci; 1986 Nov; 39(21):2017-24. PubMed ID: 3023775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat.
    Millan MJ; Członkowski A; Herz A
    Neuroscience; 1987 Sep; 22(3):885-96. PubMed ID: 2825072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kappa opioid receptor and food intake.
    Morley JE; Levine AS; Kneip J; Grace M; Zeugner H; Shearman GT
    Eur J Pharmacol; 1985 May; 112(1):17-25. PubMed ID: 2990965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta-funaltrexamine on ingestive behaviors in the rat.
    Ukai M; Holtzman SG
    Eur J Pharmacol; 1988 Aug; 153(2-3):161-5. PubMed ID: 2846315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
    Rathbun RC; Kattau RW; Leander JD
    Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.
    Leander JD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):705-7. PubMed ID: 3037567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of opioid receptor subtypes in rat feeding behavior.
    Simone DA; Bodnar RJ; Goldman EJ; Pasternak GW
    Life Sci; 1985 Mar; 36(9):829-33. PubMed ID: 2983173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dog.
    Freye E; Buhl R; Schenk GK
    Funct Neurol; 1987; 2(3):281-92. PubMed ID: 2826307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.